Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
Study Identifier
PCYC-0211
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18+ years
Protocol Summary
The primary purpose of the study is to determine if patients with brain metastases from non-small cell lung cancer treated with Motexafin Gadolinium and whole brain radiation therapy retain their neurologic function and ability to think for a longer time compared to patients treated with whole brain radiation therapy alone.
Study Locations
Location
Status
Location
Phoenix, Arizona, United States
Status
Not applicable
Location
Fort Smith, Arkansas, United States
Status
Not applicable
Location
Little Rock, Arkansas, United States
Status
Not applicable
Location
Berkeley, California, United States
Status
Not applicable
Location
Concord, California, United States
Status
Not applicable
Location
Greenbrae, California, United States
Status
Not applicable
Showing {first} - {last} of {total} Results